Diagnostic performance of liver biochemical and hemostatic markers for assessing cirrhosis severity in chronic hepatitis B
- 1The First College of Clinical Medical Science, China Three Gorges University
Abstract
Background This study aimed to explore the utility of liver biochemical and hemostatic (including coagulation, anticoagulation, and fibrinolysis) markers for assessing cirrhosis severity in chronic hepatitis B (CHB) patients. Methods In this current study, a total of 28 healthy controls and 78 patients with CHB-related cirrhosis were enrolled. Routine laboratory markers including platelet count (PLT), albumin (ALB), total bilirubin (TBIL), creatinine (CREA), prothrombin time (PT), activated partial thromboplastin time (APTT), factor VIII (FVIII), prothrombin activity (PA), protein S (PS), protein C (PC), antithrombin III (AT-III) and D-dimer (D-D) were measured. Correlations between the measured parameters and Child-Pugh score (CPS)/ Model for End-Stage Liver Disease score (MELD) were also explored. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the ability of these indicators to discriminate between mild and moderate-to-severe CHB-related cirrhosis. Results Patients with CHB-related cirrhosis exhibited significantly lower levels of ALB, PA, PS, PC, AT-III, and PLT, and significantly higher levels of TBIL, PT, APTT, FVIII, and D-D, compared with healthy controls (p < 0.05). ALB, PA, AT-III, PS, and PC showed significant negative correlations with both CPS and MELD (p < 0.01). TBIL, PT, and APTT demonstrated significant positive correlations (p < 0.01). ROC curve analysis revealed that AT-III achieved an AUC of 0.95 (95% CI: 0.88–1.00) for distinguishing cirrhosis severity, followed by PC (AUC: 0.87) and PA (AUC: 0.87). As expected, Child-Pugh components (ALB, TBIL, PT) showed strong associations with the score. Conclusion Among markers not incorporated into the CPS, AT-III is significantly associated with the severity of CHB-related cirrhosis and exhibits promising discriminatory ability for staging CHB-related cirrhosis. It may support a low-cost, objective framework for dynamic monitoring of HBV-related cirrhosis progression. Although ALB, TBIL, and PT were also correlated with disease severity, these associations are subject to incorporation bias and thus represent confirmatory rather than novel findings.
Related
- Diagnostic Performance of Corrected Carotid Flow Time for Assessing Fluid Responsiveness in Patients With Septic or Hypovolemic Shock: A Prospective Diagnostic Accuracy Study
- Assessing diagnostic performance for common skin diseases using an AI-assisted tele-expertise platform: a proof of concept
- Reproducibility and diagnostic performance of ADC for assessing response to neoadjuvant immunotherapy in muscle-invasive bladder cancer: a multi-ROI comparison analysis from the phase-Ib NABUCCO trial
- Viscoelastic Hemostatic Testing as a Diagnostic Tool for Trauma-Induced Coagulopathy with a Focus on Arabian Gulf Countries: A Narrative Review
- A Diagnostic Conundrum: A Hemorrhagic Adrenal Mass With Discordant Radiological, Biochemical, and Pathologic Features
BibTeX
@article{luo2026diagnostic,
title = {{Diagnostic performance of liver biochemical and hemostatic markers for assessing cirrhosis severity in chronic hepatitis B}},
author = {Chunhua Luo and Yucheng Luo and Qianyuan Li and Xiaolin Zhou and Jun Luo},
journal = {BMC Gastroenterology},
year = {2026},
month = jul,
doi = {10.1186/s12876-026-05178-6},
url = {https://doi.org/10.1186/s12876-026-05178-6},
note = {CC BY},
}
RIS
TY - JOUR
TI - Diagnostic performance of liver biochemical and hemostatic markers for assessing cirrhosis severity in chronic hepatitis B
AU - Chunhua Luo
AU - Yucheng Luo
AU - Qianyuan Li
AU - Xiaolin Zhou
AU - Jun Luo
PY - 2026
DA - 2026/07/01
JO - BMC Gastroenterology
DO - 10.1186/s12876-026-05178-6
UR - https://doi.org/10.1186/s12876-026-05178-6
AB - Background This study aimed to explore the utility of liver biochemical and hemostatic (including coagulation, anticoagulation, and fibrinolysis) markers for assessing cirrhosis severity in chronic hepatitis B (CHB) patients. Methods In this current study, a total of 28 healthy controls and 78 patients with CHB-related cirrhosis were enrolled. Routine laboratory markers including platelet count (PLT), albumin (ALB), total bilirubin (TBIL), creatinine (CREA), prothrombin time (PT), activated partial thromboplastin time (APTT), factor VIII (FVIII), prothrombin activity (PA), protein S (PS), protein C (PC), antithrombin III (AT-III) and D-dimer (D-D) were measured. Correlations between the measured parameters and Child-Pugh score (CPS)/ Model for End-Stage Liver Disease score (MELD) were also explored. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the ability of these indicators to discriminate between mild and moderate-to-severe CHB-related cirrhosis. Results Patients with CHB-related cirrhosis exhibited significantly lower levels of ALB, PA, PS, PC, AT-III, and PLT, and significantly higher levels of TBIL, PT, APTT, FVIII, and D-D, compared with healthy controls (p < 0.05). ALB, PA, AT-III, PS, and PC showed significant negative correlations with both CPS and MELD (p < 0.01). TBIL, PT, and APTT demonstrated significant positive correlations (p < 0.01). ROC curve analysis revealed that AT-III achieved an AUC of 0.95 (95% CI: 0.88–1.00) for distinguishing cirrhosis severity, followed by PC (AUC: 0.87) and PA (AUC: 0.87). As expected, Child-Pugh components (ALB, TBIL, PT) showed strong associations with the score. Conclusion Among markers not incorporated into the CPS, AT-III is significantly associated with the severity of CHB-related cirrhosis and exhibits promising discriminatory ability for staging CHB-related cirrhosis. It may support a low-cost, objective framework for dynamic monitoring of HBV-related cirrhosis progression. Although ALB, TBIL, and PT were also correlated with disease severity, these associations are subject to incorporation bias and thus represent confirmatory rather than novel findings.
SN - 1471-230X
ER -